2m 2m 2m 2m 2m 2m 2m
HEALTH IN-A (HIT)
NASDAQ
$0.96-$0.003 (-0.31%)
Price as of Jun 03, 2026 7:37 PM EDT- $53.4MMarket Cap
- 68.50%1-Year Change
- Software - ApplicationIndustry
HEALTH IN-A (HIT)
$0.96-$0.003 (-0.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 6.9M -64.78% | 19.5M N/A | |
Cost of Revenue | 12.4M +205.81% | 4.1M N/A | |
Gross Profit | 20.9M +35.61% | 15.4M N/A | |
Sales and Marketing Expense | 4.2M +32.53% | 3.2M N/A | |
Research and Development Expense | -1.6M -44.23% | -2.8M N/A | |
Depreciation and Amortization Expense | 900,577 +66.42% | 541,141 N/A | |
Total Operating Expenses | 19.4M +34.32% | 14.4M N/A | |
Operating Profit | 1.7M +88.32% | 889,000 N/A | |
Interest Income | 409,922 +233.58% | 122,885 N/A | |
Interest Expense | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 409,922 +233.58% | 122,885 N/A | |
Total Nonoperating Income and Expense | 145,734 +244.43% | -100,904 N/A | |
Income before Taxes | 1.7M +88.32% | 889,000 N/A | |
Income Taxes | 395,330 +80.91% | 218,523 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 1.3M +90.74% | 670,477 N/A | |
Net Income from Continuing Operations Applicable to Common | 1.7M +149.70% | 670,477 N/A | |
Basic EPS and Net Income | 0.02 +100.00% | 0.01 N/A | |
Diluted EPS and Net Income | 0.02 +100.00% | 0.01 N/A | |
Basic Weighted Average Shares | 55.8M -46.14% | 103.7M N/A | |
Diluted Weighted Average Shares | 57.7M -46.20% | 107.3M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 7.7M -2.29% | 7.8M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.7M -2.29% | 7.8M N/A | |
Total Current Assets | 16.2M +49.86% | 10.8M N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | |
Total Long-Term Assets | 6.9M +39.00% | 5.0M N/A | |
Total Assets | 23.1M +46.43% | 15.8M N/A | |
Income Taxes Payable | 757,675 +41.91% | 533,929 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | |
Total Current Liabilities | 5.2M +141.98% | 2.1M N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 821,292 +75.31% | 468,487 N/A | |
Total Liabilities | 6.0M +129.97% | 2.6M N/A | |
Retained Earnings | 5.2M +32.45% | 3.9M N/A | |
Total Stockholders Equity | 17.1M +29.94% | 13.2M N/A | |
Total Shares Outstanding | 46.0M -57.88% | 109.2M N/A | |
Cash Flow | |||
Cash from Operating Activities | 3.1M +44.00% | 2.2M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | -3.1M +273.58% | -836,755 N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | -187,386 -104.58% | 4.1M N/A | |
Financials Ratio | |||
Gross Margin | -80.49% N/A | N/A N/A | |
Operating Margin | 24.39% N/A | N/A N/A | |
Return on Assets | 6.58% N/A | N/A N/A | |
Return on Equity | 8.45% N/A | N/A N/A | |
Revenue Growth | -64.78% N/A | N/A N/A | |
Current Ratio | 3.13 N/A | N/A N/A | |
Cash Ratio | 1.49 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow